1MAZZUCCONI MG,FAZI P,BERNASCONI S,et al.Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura:a GIMEMA ex perience[J].Bload,2007,109(4):111-116. 被引量：1
2CHOUDHARY D.R,NAITHANI R,MAHAPATRA M,et al.Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura[J].Haematologica,2008,93:61-62. 被引量：1
3RYFFEL BD.Cyclosporine acellular activation:regulation of intracellular events by cyclosporine.Pharmcol Rev,1989,41:407-412. 被引量：1
4KAPPERS-KLUNNE MC,VAN'T VEER MB.Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy[J].Br.J Haematol.2001,114(1):121-125. 被引量：1
5STAI R,PAGNO A,STIPA E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952. 被引量：1
6FRANCESCO Z,MARTA L B,MARIA P,et al.Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpuram[J].Haematologica,2008,93:930-933. 被引量：1
7FRANCESCO Z,MICHELE B,PATRIZIO M,et al.Long term follow up analysis following front line therapy with dexamethasone or dexamethasone plus rituximab in adults with primary Immune thrombocytopenia[J].Blood,2009,114:Abstract No.2415. 被引量：1
8GREGORY C,TERRY G,HAROLD J.OLNEY,et al.Time to splenectomy failure in patients with recurrent or refractory chronic lmmune thrombocytopenic purpura[J].Blood,2009,114:Abstract No.3522. 被引量：1
9SAMANTHA M.JAGLOWSKI,JOHN CB,et al.In-hospital mortality and trends associated with splenectomy in patients with immune-mediated thrombocytopenia (ITP)[J].Blood,2009,114:Abstract No.1398. 被引量：1
10SAMUELSSON A,TOWERS TL,RAVETCH JV.Anti-inflammaitory activityof IV IGmediated through the inhibitory Fc recep tor[J].Science,2001,291:445-446. 被引量：1
